market - International Pharmaceutical Industry

Volume 16 Issue 1

Generative AI and its Impact on Speed to Market for Pharmaceuticals

Did you know that it takes approximately seven years to develop and bring a new drug to market? However, this time can be significantly reduced by months or even yea...

15 April 2024 Volume 16 Issue 1 | Editorial Archive accelerate | AI

Continue Reading →

Volume 15 Issue 3

Rethink, Redesign, Recycle – Pharma’s 100% PET Blister

IPI Speaks with Alberto Negra, Technical Manager at Rotor Print about creating a pharmaceutical blister that can be recycled, but without losing the properties of th...

29 September 2023 Volume 15 Issue 3 Blister | idea

Continue Reading →

Volume 15 Issue 3

Keeping eCOAs Off the Critical Path – Key Considerations

The prevalence of decentralised clinical trials, rising demand for preventive healthcare solutions, a market driven by the need for more and better-quality data and ...

29 September 2023 Volume 15 Issue 3 clinical | Critical

Continue Reading →

Volume 15 Issue 3

Can a Modular Approach to Cleanroom Technology Deliver Flexible Sterile Manufacturing Capacity?

Trista Hager, Vice President of Sales at AES Clean Technology, explores the challenges facing pharmaceutical manufacturers in expanding their cleanroom capacity to m...

29 September 2023 Volume 15 Issue 3 Capacity | cleanroom

Continue Reading →

Volume 15 Issue 3

How to Make the Grade in Pharma Manufacturing

The current era in pharmaceutical manufacturing is defined by challenging market demands and stricter regulations, particularly with new, more comprehensive GMP stan...

29 September 2023 Volume 15 Issue 3 automation | comprehensive

Continue Reading →

Volume 15 Issue 3

High Potent Manufacture

The global market for drug products containing highly potent active pharmaceutical ingredients (HPAPIs) is currently on a growth fast track. Data indicates a Compoun...

29 September 2023 Volume 15 Issue 3 active | drug

Continue Reading →

Volume 15 Issue 2

How to Harness the Benefits of Inhalation When Re-formulating Biologics

The biologics market is growing rapidly and is on track to be worth $719.14 bn by 2030, up from $366.6 bn in 2021.¹ This growth is being driven primarily by the risi...

3 July 2023 Volume 15 Issue 2 Benefits | biologics

Continue Reading →

Volume 15 Issue 2

Cutting-edge Formulation is Needed to Enable the Next Generation of Oral Biologics

An Introduction to Oral Solid Dose Traditionally, the pharmaceutical market has been dominated by oral drug delivery – whether oral solid dose (OSD) or liquid suspen...

3 July 2023 Volume 15 Issue 2 biologics | cutting-edge

Continue Reading →

Volume 15 Issue 2

Effective Operations for Risk Reduction and Supply Chain Resilience

There is no denying that the market for injectable drug delivery devices is growing rapidly, with forecasts predicting an increase from $39.93 billion in 2022 to $43...

3 July 2023 Volume 15 Issue 2 chain | delivery

Continue Reading →

Volume 15 Issue 1

Navigating the Changing Oral Solid Dose Landscape

Oral solid dose (OSD) forms have accounted for the lion’s share of the pharmaceutical market for decades, thanks to their easy administration leading to patient conv...

4 April 2023 Volume 15 Issue 1 development | dosage

Continue Reading →